Tenet Healthcare Corporation (THC)
 NYSE: THC · Real-Time Price · USD
 206.49
 -2.13 (-1.02%)
  At close: Oct 31, 2025, 4:00 PM EDT
206.49
 0.00 (0.00%)
  After-hours: Oct 31, 2025, 7:00 PM EDT
Tenet Healthcare Market Cap
Tenet Healthcare has a market cap or net worth of $18.15 billion as of October 31, 2025. Its market cap has increased by 18.18% in one year.
Market Cap 
 18.15B
Enterprise Value 
 28.36B
1-Year Change 
 18.18%
Ranking 
 Category 
 Stock Price 
$206.49
Market Cap Chart
Since December 1, 1998, Tenet Healthcare's market cap has increased from $9.27B to $18.15B, an increase of 95.76%. That is a compound annual growth rate of 2.53%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 30, 2025 | 18.33B | 52.74% | 
| Dec 31, 2024 | 12.00B | 56.42% | 
| Dec 29, 2023 | 7.67B | 45.48% | 
| Dec 30, 2022 | 5.28B | -39.72% | 
| Dec 31, 2021 | 8.75B | 107.70% | 
| Dec 31, 2020 | 4.21B | 6.64% | 
| Dec 31, 2019 | 3.95B | 124.90% | 
| Dec 31, 2018 | 1.76B | 14.81% | 
| Dec 29, 2017 | 1.53B | 3.49% | 
| Dec 30, 2016 | 1.48B | -51.04% | 
| Dec 31, 2015 | 3.02B | -39.36% | 
| Dec 31, 2014 | 4.98B | 19.15% | 
| Dec 31, 2013 | 4.18B | 20.89% | 
| Dec 31, 2012 | 3.46B | 55.16% | 
| Dec 30, 2011 | 2.23B | -31.40% | 
| Dec 31, 2010 | 3.25B | 25.25% | 
| Dec 31, 2009 | 2.59B | 372.63% | 
| Dec 31, 2008 | 548.70M | -77.22% | 
| Dec 31, 2007 | 2.41B | -26.69% | 
| Dec 29, 2006 | 3.29B | -8.64% | 
| Dec 30, 2005 | 3.60B | -29.83% | 
| Dec 31, 2004 | 5.12B | -31.31% | 
| Dec 31, 2003 | 7.46B | -6.73% | 
| Dec 31, 2002 | 8.00B | -58.15% | 
| Dec 31, 2001 | 19.11B | 35.64% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 758.96B | 
| Johnson & Johnson | 455.36B | 
| AbbVie | 404.08B | 
| UnitedHealth Group | 312.63B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 217.35B |